Physician profile
Adnan Sultan
NPI 1659635381
$7,740.99
in general payments reported to CMS, 2019-2025
30 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,931 · 2020: $130 · 2021: $210 · 2022: $352 · 2023: $4,295 · 2024: $686 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,772 · Travel and Lodging: $2,347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,771.62 |
| Travel and Lodging | $2,346.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,255.85 | 2019-2024 | Amplatzer Amulet, Jeti Peripheral Catheter, Cardiomems |
| Angiodynamics, INC. | $1,321.49 | 2019-2023 | Auryon Laser System 100-120 Vac |
| Penumbra, INC. | $728.92 | 2023-2024 | Indigo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $384.73 | 2020-2025 | Lifevest |
| Boston Scientific Corporation | $373.43 | 2019-2025 | Bodyguardian, Cds - Mct/Cem Monitoring |
| Janssen Pharmaceuticals, INC | $321.56 | 2020-2024 | Xarelto |
| Teleflex LLC | $225.48 | 2023 | Turnpike, Trapliner |
| Amgen INC. | $196.84 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $118.81 | 2020-2024 | |
| Novartis Pharmaceuticals Corporation | $109.52 | 2023-2025 | |
| Atricure, INC. | $95.17 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $83.39 | 2019-2023 | Andexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.19 | 2019-2024 | Jardiance |
| Abiomed | $55.73 | 2019 | |
| Cvrx, INC. | $48.09 | 2024 | Barostim Neo System |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $36.93 | 2024 | Onpattro |
| Amarin Pharma, INC. | $32.48 | 2020-2021 | |
| Actelion Pharmaceuticals US, INC. | $30.35 | 2022 | |
| Ethicon US, LLC | $29.59 | 2024 | Dermabond Prineo, Surgicel Nu-Knit, Ethicon |
| Merck Sharp & Dohme LLC | $28.83 | 2022-2023 | |
| Inspire Medical Systems, INC. | $28.65 | 2023-2024 | Inspire |
| Kowa Pharmaceuticals America, INC. | $27.67 | 2019 | |
| Baxter Healthcare | $21.70 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $21.70 | 2023 | |
| Siemens Medical Solutions USA, INC. | $17.21 | 2024 | Cios Spin |
| Electromed, INC. | $16.50 | 2023 | Smartvest |
| Terumo Medical Corporation | $16.43 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $14.89 | 2024 | Eliquis |
| Philips North America LLC | $13.31 | 2023 | |
| Kls-Martin L.P. | $8.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adnan Sultan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.